Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350334

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350334

Cannabidiol (CBD) Consumer Health Market, By Products, By Distribution Channel, By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The global cannabidiol (CBD) consumer health market was valued at US$ 14.7 Bn in 2022 and is forecast to reach a value of US$ 82.0 Bn by 2030 at a CAGR of 23.2% between 2023 and 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 19.0 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 23.20% 2030 Value Projection: US$ 82.0 Bn
Cannabidiol (CBD) Consumer Health Market - IMG1

Cannabidiol (CBD) is a compound commonly found in hemp and marijuana plants, this extract is found to be effective against numerous disorders such as chronic pain, neurological pain, anxiety, sleep disorder, as well as nausea and stress. Hence, cannabidiol is gaining widespread popularity across various regions. This extract consists approximately 40% of the entire plant and it is known to not cause any dependence effects on the human body. CBD is found naturally in marijuana plants. Though the oil is derived from marijuana, it does not have any harmful effects like any other product derived from cannabis. CBD oil is also showing positive results in treating various health disorders such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, and others.

Market Dynamics:

CBD-infused products have become the latest trend across the world. Increasing awareness about the medical benefits of CBD-infused products is leading to an increase in the number of people willing to buy these products, irrespective of cost and this is expected to augment the growth of the global cannabidiol (CBD) consumer health market during the forecast period.

In the Asia Pacific region, several nutraceutical companies are now offering a wide variety of supplements and functional foods in various forms. For instance, an Australian company-MGC Pharma-launched its CBD nutraceutical-product line, including CBD capsules, water-soluble CBD solutions, and hemp powder, in China. These products have gained significant acceptance among consumers within a short span, as they offer health benefits of CBD without any psychoactive effects. In addition, the demand for hemp-derived CBD products is increasing due to the legalization of hemp in various countries in the Asia Pacific region.

Key features of the study:

  • This report provides in-depth analysis of the global cannabidiol (CBD) consumer health market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cannabidiol (CBD) consumer health market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include CV Sciences, Inc., Medical Marijuana, Inc., AXIM-Biotechnologies, Inc., Charlotte's Web, Endoca, Isodiol International Inc., Elixinol, Folium Biosciences, NuLeaf Naturals, LLC, Cannoid, LLC, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cannabidiol (CBD) consumer health market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol (CBD) consumer health market.

Detailed Segmentation:

  • Global Cannabidiol (CBD) Consumer Health Market, By Products:
    • Medical OTC Products Targeted Therapy
    • Analgesics
    • Dermatology
    • Mental Health
    • Sleeping Aids
    • Others
    • Nutraceuticals
    • CBD Vitamins and Dietary Supplements (VDS)
    • CBD Sports Nutrition
    • CBD Weight Management and Wellbeing
  • Global Cannabidiol (CBD) Consumer Health Market, By Distribution Channel:
    • Online Stores
    • Retail Pharmacies
    • Retail Stores
  • Global Cannabidiol (CBD) Consumer Health Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • CV Sciences, Inc.
    • Medical Marijuana, Inc.
    • AXIM-Biotechnologies, Inc.
    • Charlotte's Web
    • Endoca
    • Isodiol
    • Elixinol
    • Folium Biosciences
    • Cannoid, LLC
Product Code: CMI6126

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Products
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Cannabis revolution positively impacting consumer health market
    • Availability of alternatives to CBD supplements
    • Uncertain government regulations related to CBD and CBD products
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Cannabidiol (CBD) Consumer Health Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cannabidiol (CBD) Consumer Health Market, By Products, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Medical OTC Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Analgesics
  • Dermatology
  • Mental Health
  • Sleeping Aids
  • Others
  • Nutraceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • CBD Vitamins and Dietary Supplements (VDS)
  • CBD Sports Nutrition
  • CBD Weight Management and Wellbeing

6. Global Cannabidiol (CBD) Consumer Health Market, By Distribution Channel, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Online Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Retail Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Cannabidiol (CBD) Consumer Health Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)

8. Competitive Landscape

  • CV Sciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medical Marijuana, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AXIM-Biotechnologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Charlotte's Web
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Endoca
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Isodiol
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elixinol
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Folium Biosciences
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NuLeaf Naturals, LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cannoid, LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!